Harris Health System-Smith Clinic

Houston, Texas 77054

4 studies enrolling now · 19 studies all time

What they study most

Atypical Ductal Hyperplasia, Atypical Lobular Hyperplasia, Bladder Cancer, Breast Cancer, Breast Cancer Female, Breast Cancer Invasive, Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage IV, Breast Neoplasm, Carcinoma, Hepatocellular, Chronic Myeloid Leukemia

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer — Recruiting now
• Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer — Recruiting now
• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause — Completed
• Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer — Completed
• Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population — Running, not enrolling
• Ruxolitinib for Premalignant Breast Disease — Completed
• A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer — Stopped early
• Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ) — Stopped early
• TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer — Completed
• Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer — Running, not enrolling
• Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer — Running, not enrolling
• Meclizine for Hepatocellular Carcinoma — Completed
• Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix — Stopped early
• Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo — Running, not enrolling
• Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma — Completed
• Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers — Stopped early